Amphastar Pharmaceuticals Inc vs Huntington Ingalls Industries Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Huntington Ingalls Industries Inc trades at $327.5 (market cap $12.92B). The key difference: Huntington Ingalls Industries Inc is far larger — about 14.9× Amphastar Pharmaceuticals Inc's market cap, and Huntington Ingalls Industries Inc pays a 1.68% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | HII | |
|---|---|---|
Market Cap | $868.62M | $12.92B |
Sector | Health | Technology |
52-Week High | $30.81 | $453.73 |
52-Week Low | $16.87 | $265.40 |
Enterprise Value | $1.27B | $15.84B |
Dividend Yield | — | 1.68% |
Trailing returns across standard periods
Latest headlines on both assets
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →Huntington Ingalls is the largest military shipbuilder in the U.S. and a provider of professional services to government and industry partners, specializing in nuclear-powered submarines and aircraft carriers.
Read more on HII →